Literature DB >> 18450738

Confirmation of the utility of the International Staging System and identification of a unique pattern of disease in Brazilian patients with multiple myeloma.

Vania T M Hungria, Angelo Maiolino, Gracia Martinez, Gisele W B Colleoni, Erika O D M Coelho, Laís Rocha, Renata Nunes, Rosane Bittencourt, Luciana C O Oliveira, Rosa Malena O Faria, Ricardo Pasquini, Sílvia M M Magalhães, Cármino A Souza, Jorge V Pinto Neto, Luciana Barreto, Elizabeth Andrade, Maria do Socorro O Portella, Vanessa Bolejack, Brian G M Durie.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18450738     DOI: 10.3324/haematol.11637

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  16 in total

1.  Fractal characteristics of May-Grünwald-Giemsa stained chromatin are independent prognostic factors for survival in multiple myeloma.

Authors:  Daniela P Ferro; Monica A Falconi; Randall L Adam; Manoela M Ortega; Carmen P Lima; Carmino A de Souza; Irene Lorand-Metze; Konradin Metze
Journal:  PLoS One       Date:  2011-06-16       Impact factor: 3.240

2.  Guidelines on the diagnosis and management of multiple myeloma treatment: Associação Brasileira de Hematologia e Hemoterapia e Terapia Celular Project guidelines: Associação Médica Brasileira - 2012.

Authors:  Vânia Tietsche de Moraes Hungria; Edvan de Queiroz Crusoe; Adriana Alvarez Quero; Manuella Sampaio; Angelo Maiolino; Wanderley Marques Bernardo
Journal:  Rev Bras Hematol Hemoter       Date:  2013

3.  Clinical and epidemiological features of multiple myeloma patients from a low socio-economic region of Brazil.

Authors:  Carolina Minnicelli; James Farley Rafael Maciel; Rocio Hassan; Telma Maria Araújo Moura Lemos
Journal:  Rev Bras Hematol Hemoter       Date:  2015-07-02

4.  Epidemiology of multiple myeloma in 17 Latin American countries: an update.

Authors:  Maria Paula Curado; Max M Oliveira; Diego R M Silva; Dyego L B Souza
Journal:  Cancer Med       Date:  2018-03-24       Impact factor: 4.452

5.  Is the International Staging System superior to the Durie-Salmon staging system? A comparison in multiple myeloma patients undergoing autologous transplant.

Authors:  P N Hari; M-J Zhang; V Roy; W S Pérez; A Bashey; L B To; G Elfenbein; C O Freytes; R P Gale; J Gibson; R A Kyle; H M Lazarus; P L McCarthy; G A Milone; S Pavlovsky; D E Reece; G Schiller; J Vela-Ojeda; D Weisdorf; D Vesole
Journal:  Leukemia       Date:  2009-03-26       Impact factor: 11.528

6.  FOXP3 and CTLA4 overexpression in multiple myeloma bone marrow as a sign of accumulation of CD4(+) T regulatory cells.

Authors:  Walter Moises Tobias Braga; Bruna Raphaeli da Silva; Ana Carolina de Carvalho; Yumi H Maekawa; Adriana Bruscato Bortoluzzo; Edgar Gil Rizzatti; Djordje Atanackovic; Gisele Wally Braga Colleoni
Journal:  Cancer Immunol Immunother       Date:  2014-08-07       Impact factor: 6.968

7.  Mature B cell neoplasms: retrospective analysis of 93 cases diagnosed between 2011 and 2014 in a University Hospital in southern Brazil.

Authors:  Chandra Chiappin Cardoso; Ana Carolina Rabello de Moraes; Joanita Angela Gonzaga Del Moral; Maria Claudia Santos-Silva
Journal:  Rev Bras Hematol Hemoter       Date:  2016-03-09

8.  Genetic aberrations in multiple myeloma characterized by cIg-FISH: a Brazilian context.

Authors:  P Segges; E Braggio; C Minnicelli; R Hassan; I R Zalcberg; A Maiolino
Journal:  Braz J Med Biol Res       Date:  2016-04-08       Impact factor: 2.590

9.  "Punched out" multiple myeloma lytic lesions in the skull.

Authors:  Vanessa Munhoz Bitelman; Josélia Alexandra Dinis de Oliveira Lopes; Ariel Barreto Nogueira; Fernando Pereira Frassetto; Amaro Nunes Duarte-Neto
Journal:  Autops Case Rep       Date:  2016-03-30

10.  Pharmacovigilance of patients with multiple myeloma being treated with bortezomib and/or thalidomide.

Authors:  T B M Castro; A E Hallack Neto; A Atalla; L C Ribeiro
Journal:  Braz J Med Biol Res       Date:  2016-05-31       Impact factor: 2.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.